NanoViricides, Inc. (NNVC)
NYSEAMERICAN: NNVC · Real-Time Price · USD
1.190
-0.020 (-1.65%)
Apr 29, 2026, 2:50 PM EDT - Market open
NanoViricides Market Cap
NanoViricides has a market cap or net worth of $25.70 million as of April 29, 2026. Its market cap has increased by 47.69% in one year.
Market Cap
25.70M
Enterprise Value
20.48M
1-Year Change
47.69%
Ranking
Category
Stock Price
$1.19
Market Cap Chart
Since September 25, 2013, NanoViricides's market cap has decreased from $293.90M to $25.70M, a decrease of -91.26%. That is a compound annual growth rate of -17.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 26.10M | 28.57% |
| Dec 31, 2025 | 20.30M | -0.98% |
| Dec 31, 2024 | 20.50M | 70.83% |
| Dec 29, 2023 | 12.00M | -6.98% |
| Dec 30, 2022 | 12.90M | -69.93% |
| Dec 31, 2021 | 42.90M | 40.20% |
| Dec 31, 2020 | 30.60M | 215.46% |
| Dec 31, 2019 | 9.70M | -30.22% |
| Dec 31, 2018 | 13.90M | -75.04% |
| Dec 29, 2017 | 55.70M | -10.59% |
| Dec 30, 2016 | 62.30M | -8.38% |
| Dec 31, 2015 | 68.00M | -56.21% |
| Dec 31, 2014 | 155.30M | -35.32% |
| Dec 31, 2013 | 240.10M | -18.31% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apollomics | 28.52M |
| BriaCell Therapeutics | 28.09M |
| Polyrizon | 27.74M |
| Lantern Pharma | 27.57M |
| Longeveron | 27.52M |
| Neuphoria Therapeutics | 27.17M |
| AEON Biopharma | 26.57M |
| NeuroSense Therapeutics | 26.52M |